| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/31/2008 | EP2007418A1 Reversibly inhibited antibodies for immune cell stimulation |
| 12/31/2008 | EP2007410A1 Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides |
| 12/31/2008 | EP2007360A1 Controlled release delivery device comprising an organosol coat |
| 12/31/2008 | EP2007356A1 Lipoplex formulations for specific delivery to vascular endothelium |
| 12/31/2008 | EP2007350A2 Degradable therapeutic delivery device |
| 12/31/2008 | EP2007349A1 Aerosol suspension formulations comprising tg 227 ea or tg 134 a as propellants |
| 12/31/2008 | EP1928469A4 Fulvestrant formulation |
| 12/31/2008 | EP1638539B1 Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug |
| 12/31/2008 | EP1628659B1 Use of poly-aminopyrrolecarboxamides in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
| 12/31/2008 | EP1569724B1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 12/31/2008 | EP1534823A4 The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| 12/31/2008 | EP1501501B1 Method for oxygen treatment of unsaturated carbon compounds, novel epoxy-structured material obtained by the method, apparatus for carrying out the method and a therapeutic composition using the material |
| 12/31/2008 | EP1492506B1 Matrix for sustained, invariant and independent release of active compounds |
| 12/31/2008 | EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 12/31/2008 | EP1423151B1 Light-stabilized in vivo stain composition and method of manufacture |
| 12/31/2008 | EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 12/31/2008 | EP1337217B1 Methods and apparatus for making seamless capsules |
| 12/31/2008 | EP1296672B1 Stable pharmaceutical product and formulation |
| 12/31/2008 | EP1266009B1 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 12/31/2008 | EP0937153B1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 12/31/2008 | EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/31/2008 | EP0759937B2 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 12/31/2008 | EP0743860B2 Preparation of hollow microcapsules |
| 12/31/2008 | CN101332508A Needle shaped porous iron granule cladded by silicon and manufacture method thereof |
| 12/31/2008 | CN101332311A Drug-loaded mesh grid with slow-release function, production method and use thereof |
| 12/31/2008 | CN101332304A Campylobacter jejuni chitose nano DNA vaccine and preparation method and use thereof |
| 12/31/2008 | CN101332286A Traditional Chinese medicine composition for treating skin disease and preparation method thereof |
| 12/31/2008 | CN101332265A External preparation for treating skin persistent ailment, e.g. tinea capitis, tinea corporis |
| 12/31/2008 | CN101332237A Traditional Chinese medicine composition for treating the prostatitis and preparation method thereof |
| 12/31/2008 | CN101332236A Jinshile in-situ-forming eye gel |
| 12/31/2008 | CN101332206A Anticancer composition loaded with anti-metabolism and synergist thereof |
| 12/31/2008 | CN101332204A Anticancer composition containing phosphoinositide 3-kinase inhibitor and topology enzyme inhibitor |
| 12/31/2008 | CN101332203A Medicine for preventing and curing porcine diarrhea |
| 12/31/2008 | CN101332202A Tobramycin lotion and preparation method thereof |
| 12/31/2008 | CN101332201A Anticancer composition containing irinotecan |
| 12/31/2008 | CN101332199A Anticancer composition containing phosphoinositide 3-kinase inhibitor and topology enzyme inhibitor |
| 12/31/2008 | CN101332196A Amoxicillin/clavulanate potassium dispersible tablets and preparation method thereof |
| 12/31/2008 | CN101332194A Compound atenolol tablet and preparation method thereof |
| 12/31/2008 | CN101332191A Stable perindopril tert-butylamine salt tablets and preparation method thereof |
| 12/31/2008 | CN101332190A Sugar-free type citrulline effervescence tablet and preparation method thereof |
| 12/31/2008 | CN101332187A Aminophenylsulfone liposome and preparation method thereof |
| 12/31/2008 | CN101332185A SiRNA liposome preparation |
| 12/31/2008 | CN101332183A O/W emulsification preparation containing steride |
| 12/31/2008 | CN101332181A Anticancer composition containing irinotecan |
| 12/31/2008 | CN101332179A Anticancer composition containing lurtotecan |
| 12/31/2008 | CN101332178A Medicinal preparation for oral darifenacin or medicine salt thereof |
| 12/31/2008 | CN101332177A Solid preparation containing ibuprofen, tranexamic acid and calcium silicate |
| 12/31/2008 | CN101332175A Preparation technique of protein microsphere suppository |
| 12/31/2008 | CN101332173A Betaxolol hydrochloride in-situ-forming eye gel |
| 12/31/2008 | CN101332172A Dipivefrin hydrochlorideusp in-situ-forming eye gel |
| 12/31/2008 | CN101332171A Sodium chloride in-situ-forming eye gel |
| 12/31/2008 | CN100447319C Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application |
| 12/31/2008 | CN100447174C Polyurethane and use thereof for modifying rheological properties |
| 12/31/2008 | CN100446831C Method for removing organic solvent from heavy-bodied liquid |
| 12/31/2008 | CN100446820C Multiple compartment bag assembly for dialysis fluid |
| 12/31/2008 | CN100446814C Compound econazole nitrate film forming gel composition and its use |
| 12/31/2008 | CN100446811C Composition comprising immunogenic microparticles |
| 12/31/2008 | CN100446809C Injectable depot composition |
| 12/31/2008 | CN100446773C Compound micro-cream for acne treatment and preparation method thereof |
| 12/31/2008 | CN100446770C Water aerosol containing beclomethasone dipropionate |
| 12/31/2008 | CN100446769C Medicine releasing composition for improving steroid compound stability |
| 12/31/2008 | CN100446763C Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin |
| 12/31/2008 | CN100446762C (-)-epigallocatechin gallate solid dispersion and its prepn and application |
| 12/31/2008 | CN100446760C Medicated chitin fiber for treating and preventing proliferation of mammary gland, prepn. method and application thereof |
| 12/31/2008 | CN100446756C Preparation of composite drug-loaded nanoparticles of carboxyl-chitosan and chitosan modified by glycyrrhizanates |
| 12/31/2008 | CN100446753C Clotrimazole gel, and its prepn. method |
| 12/31/2008 | CA2728386A1 Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| 12/31/2008 | CA2694238A1 Pharmaceutical aerosol compositions comprising fluticasone |
| 12/31/2008 | CA2692263A1 Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 12/31/2008 | CA2692191A1 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| 12/31/2008 | CA2692165A1 Compositions of specific binding agents to hepatocyte growth factor |
| 12/31/2008 | CA2690554A1 Hydrolysable polymeric fmoc - linker |
| 12/31/2008 | CA2690244A1 Metap-2 inhibitor polymersomes for therapeutic administration |
| 12/30/2008 | US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 12/30/2008 | US7470802 hydroxy, alkoxy, amino, sulfo or carboxy terminated polyether is linked to an fatty acid acrylated polyol through ester, amide or thioester linkage; useful intermediates for preparing aggregates that can be used in drug delivery applications; for encapsulating a therapeutical agent |
| 12/30/2008 | US7470781 Formulation of stabilized cationic transfection agent(s)/nucleic acid particles |
| 12/30/2008 | US7470775 Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins |
| 12/30/2008 | US7470674 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 12/30/2008 | US7470663 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 12/30/2008 | US7470661 Delivery of superoxide dismutase to neuronal cells |
| 12/30/2008 | US7470437 Utilizing nanocrystalline silver metal, alloy or compound for mucosal, serosal, respiratory, circulatory and/or musculo-skeletal conditions |
| 12/30/2008 | US7470436 Water-soluble composition containing coenzyme Q10 |
| 12/30/2008 | US7470429 Pretargeting enzyme to mammalian target site, administering cytotoxic drug known to act at target site, or prodrug form thereof which is converted to the drug in situ, which drug is detoxified then reverted by enzyme to toxic form at site |
| 12/30/2008 | US7470422 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 12/30/2008 | US7470397 Disintegratable films for diagnostic devices |
| 12/30/2008 | US7469488 Control of process humidity to produce large, porous particles |
| 12/30/2008 | CA2512315C Biodegradable ocular implant |
| 12/30/2008 | CA2501601C Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x using small unilamellar vesicles |
| 12/30/2008 | CA2495527C New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 12/30/2008 | CA2432546C Gel for the treatment of cats and dogs |
| 12/30/2008 | CA2387873C Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 12/30/2008 | CA2355269C Materials and methods for making improved micelle compositions |
| 12/30/2008 | CA2327398C Methods and compositions for stabilizing acetylcholine compositions |
| 12/30/2008 | CA2304958C Bioadhesive compositions and methods for topical administration of active agents |
| 12/30/2008 | CA2299423C Taste-masked pharmaceutical composition |
| 12/30/2008 | CA2288482C Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis |
| 12/30/2008 | CA2285389C Use of cytoskeletal inhibitors for the prevention of restenosis |
| 12/30/2008 | CA2282506C Improved delivery of drugs to mucosal surfaces |
| 12/30/2008 | CA2282378C Pharmaceutical composition |
| 12/30/2008 | CA2281251C Sterol esters in tableted solid dosage forms |